Mrcc
Mostrando 1-9 de 9 artigos, teses e dissertações.
-
1. Influence of treatment access on survival of metastatic renal cell carcinoma in brazilian cancer center
ABSTRACT Background: Tyrosine kinase inhibitors (TKI) and immunotherapy improved survival in metastatic renal cell carcinoma (mRCC). Disparities in treatment access are present in healthcare systems globally. The aim of this study was to analyze survival outcomes of mRCC patients treated with first-line TKIs in the public (PHS) and private (PrS) health syst
Int. braz j urol.. Publicado em: 2021-06
-
2. Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
ABSTRACT Purpose: To elucidate the prognostic value of systemic inflammatory response in patients with metastatic renal cell carcinoma (mRCC) who are treated with sunitinib, we evaluated the prognostic role of C-reactive protein (CRP) kinetics. This study also compared prognostic models containing CRP kinetics and neutrophil-to-lymphocyte ratio (NLR) kineti
Int. braz j urol.. Publicado em: 2019-01
-
3. Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA
ABSTRACT Objectives To further elucidate which patients with metastatic renal cell carcinoma (mRCC) may benefit from cytoreductive nephrectomy (CN) before targeted therapy (TT), and to assess the overall survival of patients undergoing CN and TT versus TT alone. Materials and Methods We identified 88 patients who underwent CN at our institution prior to
Int. braz j urol.. Publicado em: 2017-06
-
4. Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience
ABSTRACT Purpose: The aim of this study was to assess the impact of sunitinib treatment in a non-screened group of patients with metastatic renal cell cancer (mRCC) treated by the Brazilian Unified Health System (SUS) at a single reference institution. Material and Methods: Retrospective cohort study, which evaluated patients with mRCC who received sunitin
Int. braz j urol.. Publicado em: 2016-08
-
5. Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients
Purpose To assess the activity, safety and treatment patterns of sunitinib in patients with poor-risk metastatic renal cell carcinoma (mRCC). Materials and Methods We retrospectively reviewed the charts of poor risk patients treated with sunitinib from October 2006 to July 2013 who met the eligibility criteria. The primary endpoint was overall survival
Int. braz j urol.. Publicado em: 2014-12
-
6. More than 10 years survival with sequential therapy in a patient with advanced renal cell carcinoma: a case report
Although radical nephrectomy alone is widely accepted as the standard of care in localized treatment for renal cell carcinoma (RCC), it is not sufficient for the treatment of metastatic RCC (mRCC), which invariably leads to an unfavorable outcome despite the use of multiple therapies. Currently, sequential targeted agents are recommended for the management o
Braz J Med Biol Res. Publicado em: 31/10/2014
-
7. Avaliação do vetor retroviral bicistrônico Codificador de endostatina e interleucina-2 Para utilização em terapia gênica anti-tumoral. / Evaluation of retroviral vector encoding bicistônico of endostatin and interleukin-2 for use in anti-tumor gene therapy
Gene therapy has been used in preclinical studies and clinical trials in order to assuage or cure a disease. Retroviral vectors are tools for gene transfer are widely used. Bicistronic vectors are attractive alternatives for treatment of complex disease. Endostatin (ES), the C-terminal fragment of collagen XVIII, is a potent angiogenesis inhibitor. At presen
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 28/07/2010
-
8. Metastatic renal cell carcinoma management
PURPOSE: To assess the current treatment of metastatic renal cell carcinoma, focusing on medical treatment options. MATERIAL AND METHODS: The most important recent publications have been selected after a literature search employing PubMed using the search terms: advanced and metastatic renal cell carcinoma, anti-angiogenesis drugs and systemic therapy; also
International braz j urol. Publicado em: 2009-06
-
9. Direções Sociais e Subjetivas no interior da Igreja Católica no Brasil - Um estudo entre CEBs e MRCC:Constituição de novos Sujeitos Sociais / Social and subjective directions inside the Brazilian Catholic Church Comparative study between CEBs and MRCC : Constitution of New Social Individuals.
O paradigma da modernidade determinou um novo formato na organização social. As instituições básicas iniciaram uma longa corrida para acompanhar as profundas mudanças que marcaram a humanidade, entre essas instituições, a Igreja Católica, diretamente atingida pelo fenômeno do secularismo, precisou rever a postura de distanciamento do mundo para con
Publicado em: 2005